A substance being studied in the treatment of some types of cancer. CI-1033 blocks the action of proteins called epidermal growth factor receptors, and may cause cancer cells to die. It is a type of tyrosine kinase inhibitor. Also called canertinib dihydrochloride.
Source: NCI Dictionary of Cancer Terms
Search the Glossary of Medical Terms
Newsletter
Sign up for the QuackTrack.org newsletter below!